Hartford Investment Management CO Charles River Laboratories International, Inc. Transaction History

Hartford Investment Management CO

$2.99 Billion
Q4 2024

A detailed history of Hartford Investment Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Hartford Investment Management CO holds 3,208 shares of CRL stock, worth $525,438. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,208

Previous 3,270 1.9%

Holding current value

$525,438

Previous $644,000 8.07%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$178.58 - $220.69 $11,071 - $13,682	-62 Reduced 1.9%	3,208 $592,000
Q3 2024 Oct 22, 2024	SELL	$187.96 - $245.29 $7,330 - $9,566	-39 Reduced 1.18%	3,270 $644,000
Q2 2024 Aug 01, 2024	SELL	$206.39 - $268.73 $2,889 - $3,762	-14 Reduced 0.42%	3,309 $683,000
Q1 2024 Apr 17, 2024	SELL	$203.52 - $273.43 $29,306 - $39,373	-144 Reduced 4.15%	3,323 $900,000
Q4 2023 Jan 23, 2024	SELL	$164.52 - $238.84 $17,439 - $25,317	-106 Reduced 2.97%	3,467 $819,000
Q3 2023 Oct 16, 2023	SELL	$194.44 - $217.61 $16,138 - $18,061	-83 Reduced 2.27%	3,573 $700,000
Q2 2023 Jul 19, 2023	SELL	$183.71 - $210.25 $130,801 - $149,698	-712 Reduced 16.3%	3,656 $768,000
Q1 2023 May 09, 2023	BUY	$191.89 - $259.92 $118,204 - $160,110	616 Added 16.42%	4,368 $881,000
Q4 2022 Jan 20, 2023	SELL	$197.11 - $250.07 $228,844 - $290,331	-1,161 Reduced 23.63%	3,752 $818,000
Q3 2022 Nov 02, 2022	BUY	$182.44 - $250.54 $1,459 - $2,004	8 Added 0.16%	4,913 $967,000
Q2 2022 Jul 22, 2022	BUY	$204.13 - $302.4 $16,942 - $25,099	83 Added 1.72%	4,905 $1.05 Million
Q1 2022 Apr 20, 2022	SELL	$255.51 - $362.11 $99,904 - $141,585	-391 Reduced 7.5%	4,822 $1.37 Million
Q4 2021 Feb 02, 2022	BUY	$351.38 - $448.68 $144,768 - $184,856	412 Added 8.58%	5,213 $1.96 Million
Q3 2021 Nov 01, 2021	SELL	$372.64 - $458.3 $207,560 - $255,273	-557 Reduced 10.4%	4,801 $1.98 Million
Q2 2021 Jul 29, 2021	BUY	$294.17 - $371.65 $1.58 Million - $1.99 Million	5,358 New	5,358 $1.98 Million
Q1 2019 Apr 29, 2019	SELL	$104.82 - $146.73 $318,862 - $446,352	-3,042 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$112.11 - $134.54 $22,758 - $27,311	-203 Reduced 6.26%	3,042 $409,000
Q2 2018 Jul 19, 2018	BUY	$102.37 - $117.25 $332,190 - $380,476	3,245 New	3,245 $364,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

51.8M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Account

Hartford Investment Management CO Charles River Laboratories International, Inc. Transaction History